SGLT2i Reduce Arrhythmic Events in Heart Failure Patients with Cardiac Implantable Electronic Devices
In HFrEF carriers of ICD/CRT-D, the use of SGLT2i resulted in significant reduction of AA and VA events.
Authors
- Domenico Filomena (ORCID: https://orcid.org/0000-0002-1515-506X)
- Roberto Badagliacca (ORCID: https://orcid.org/0000-0002-7887-5961)
- Agostino Piro (ORCID: https://orcid.org/0000-0002-5995-4963)
- Marta Palombi (ORCID: https://orcid.org/0009-0005-5092-3115)
- Vincenzo Myftari
- Nicola Pierucci (ORCID: https://orcid.org/0000-0002-5985-4081)
- Silvia Prosperi (ORCID: https://orcid.org/0009-0003-7689-4987)
- Cristina Chimenti (ORCID: https://orcid.org/0000-0001-5954-3796)
- Paolo Severino (ORCID: https://orcid.org/0000-0001-6211-4482)
- Marco Valerio Mariani (ORCID: https://orcid.org/0000-0002-9480-1209)
- Carlo Lavalle (ORCID: https://orcid.org/0000-0002-0794-4296)
- Domenico Laviola (ORCID: https://orcid.org/0009-0008-7621-5776)
- Sara Trivigno (ORCID: https://orcid.org/0000-0002-0968-7553)
- Vincenzo Mirco La Fazia (ORCID: https://orcid.org/0000-0001-7548-4685)
- Carmine Dario Vizza (ORCID: https://orcid.org/0000-0002-3540-4983)
- Pietro Cipollone
- Andrea D’Amato (ORCID: https://orcid.org/0000-0001-8227-2154)
- Josefina Magliolo
Institutions
- St David's Medical Center (US)
- Texas Cardiac Arrhythmia (US)
- Sapienza University of Rome (IT)
Publication Details
- Journal
- ESC Heart Failure
- Published
- 2025-02-07
- DOI
- https://doi.org/10.1002/ehf2.15223
- Citations
- 28
- Primary Topic
- Cardiac pacing and defibrillation studies
- Type
- article
- Field-Weighted Citation Impact
- 38.87